# CERUS CORP

CERUS CORP is a public company listed on Nasdaq as CERS, headquartered in Concord, CA, United States.

## Company overview

- **Legal name:** CERUS CORP
- **Classification:** Public company
- **Industry (SIC):** 3841 — Surgical & Medical Instruments & Apparatus
- **Headquarters:** Concord, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **Ticker:** Nasdaq: CERS
- **SEC CIK:** 0001020214

## About

CERUS CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001020214, and its reported industry is Surgical & Medical Instruments & Apparatus. In 10-K filed on 2026-03-02, it reported annual revenue of USD 233,798,000; net income of USD -15,627,000; total assets of USD 221,859,000 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2025 (period ended 2025-12-31)

- **Revenue:** $233.8M (USD 233,798,000)
- **Net income:** -$15.6M (USD -15,627,000)
- **Total assets:** $221.9M (USD 221,859,000)
- **Cash and equivalents:** $20.0M (USD 19,961,000)
- **Operating cash flow:** $4.8M (USD 4,837,000)

### FY2024 (period ended 2024-12-31)

- **Revenue:** $201.3M (USD 201,321,000)
- **Net income:** -$20.9M (USD -20,918,000)
- **Total assets:** $200.9M (USD 200,917,000)
- **Cash and equivalents:** $20.3M (USD 20,266,000)
- **Operating cash flow:** $11.4M (USD 11,359,000)

### FY2023 (period ended 2023-12-31)

- **Revenue:** $186.8M (USD 186,797,000)
- **Net income:** -$37.5M (USD -37,489,000)
- **Total assets:** $197.7M (USD 197,748,000)
- **Cash and equivalents:** $11.6M (USD 11,647,000)
- **Operating cash flow:** -$43.2M (USD -43,168,000)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $188.3M (USD 188,315,000)
- **Net income:** -$42.8M (USD -42,779,000)
- **Total assets:** $218.1M (USD 218,092,000)
- **Cash and equivalents:** $35.6M (USD 35,585,000)
- **Operating cash flow:** -$25.6M (USD -25,615,000)

## Recent SEC filings

- Form 10-Q — filed 2026-07-30 — period 2026-06-30 — 10-Q
- Form 8-K — filed 2026-07-30 — period 2026-07-30 — 8-K
- Form 8-K — filed 2026-07-10 — period 2026-07-06 — 8-K
- Form 8-K — filed 2026-06-08 — period 2026-06-05 — 8-K
- Form 8-K — filed 2026-06-03 — period 2026-06-02 — 8-K
- Form 10-Q — filed 2026-04-30 — period 2026-03-31 — 10-Q
- Form 8-K — filed 2026-04-30 — period 2026-04-30 — 8-K
- Form DEF 14A — filed 2026-04-22 — period 2026-04-22 — DEF 14A
- Form 8-K — filed 2026-04-21 — period 2026-04-17 — 8-K
- Form 8-K — filed 2026-03-16 — period 2026-03-11 — 8-K
- Form 10-K — filed 2026-03-02 — period 2025-12-31 — 10-K
- Form 8-K — filed 2026-03-02 — period 2026-03-02 — 8-K

---

Updated: 2026-10-23T05:02:54.863002+00:00

Canonical page: https://altss.com/profile/cerus-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology